Quanta Dialysis and Europlaz collaborate on dialysis machine shortage

Europlaz Technologies has been working with Quanta Dialysis Technologies to manufacture and supply the small, easy to use dialysis system, SC+, to the NHS. The Covid-19 crisis has rocketed demand in the NHS for dialysis machines as it is not uncommon for Covid-19 patients admitted to intensive care to also present with kidney failure. The critical importance of dialysis currently, and the chronic shortage, is evident. But now the first dialysis machines have already been supplied to select NHS Trusts and have treated many patients successfully in hospitals across the UK.

Quanta CEO, John E. Milad, said: “Everybody at Quanta is pulling out all the stops to support the NHS and kidney failure patients during this critical time. I would like to thank our team and our partners, and especially Europlaz, for enabling us to support the NHS during this critical time. I’m proud to see the difference we’re able to make with our small, simple and versatile haemodialysis system, SC+, by providing flexible treatment options for patients in urgent need.”

Europlaz chairman, Eddie O’Keeffe, said: “The manufacturing development of proprietary consumables for the SC+ dialysis system has been a true partnership. Whilst our partner owns the machine, designed it and is responsible for the technology, our role has been to manufacture the high-quality consumables required to connect the dialysis machine to the patient. I am delighted to see that the machines are now being used by the NHS in the fight against the dreadful COVID-19 pandemic.”